Evidence map›Paper›PMID 31621839›Full record

ArticleBiology of reproduction2020

Deleterious mtDNA mutations are common in mature oocytes.

Hong Ma, Tomonari Hayama, Crystal Van Dyken, Hayley Darby, Amy Koski, Yeonmi Lee, Nuria Marti Gutierrez, Satsuki Yamada, Ying Li, Michael Andrews and 11 more

Open access · greenAbstract read
In one paragraph

Article in Biology of reproduction, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. The role of mtDNA in oocyte quality and embryo development.Molecular reproduction and development · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Hong MaCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Tomonari HayamaCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Crystal Van DykenCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Hayley DarbyCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Amy KoskiCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Yeonmi LeeStem Cell Center, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil Songpa-gu, Seoul 05505, Republic of Korea.
Nuria Marti GutierrezCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Satsuki YamadaDepartment of Cardiovascular Medicine, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Ying LiCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Michael AndrewsDepartment of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, 3375 S.W. Terwilliger Blvd, Portland, Oregon 97239, USA.
Riffat AhmedCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Dan LiangCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Thanasup GonmaneeCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Eunju KangStem Cell Center, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil Songpa-gu, Seoul 05505, Republic of Korea.
Mohammed NasserCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Beth KemptonOregon Hearing Research Center, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239, USA.
John BrigandeOregon Hearing Research Center, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239, USA.
Trevor J McGillDepartment of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, 3375 S.W. Terwilliger Blvd, Portland, Oregon 97239, USA.
Andre TerzicDepartment of Cardiovascular Medicine, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Paula AmatoCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Shoukhrat MitalipovCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, Oregon 97239, USA.
Oregon Health & Science University · USOregon National Primate Research Center · USMayo Clinic in Arizona · USAsan Medical Center · KRUniversity of Ulsan · KR

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Horizontal mtDNA ExchangeR01AG062459 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MITALIPOV, SHOUKHRAT · 2019 to 2023
$2.8M
Evaluation of stem cell-derived retinal pigment epithelial cells for retinal diseR01EY021214 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NEURINGER, MARTHA · 2011 to 2015
$2.1M
Mitochondrial Aging and ReprogrammingR56AG045137 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MITALIPOV, SHOUKHRAT · 2015 to 2015
$523k
NEI NIH HHS R01 EY021214NIA NIH HHS R01 AG062459NIA NIH HHS R56 AG045137NIH HHS P51 OD011092
6 · The paper itself

Abstract

Heritable mitochondrial DNA (mtDNA) mutations are common, yet only a few recurring pathogenic mtDNA variants account for the majority of known familial cases in humans. Purifying selection in the female germline is thought to be responsible for the elimination of most harmful mtDNA mutations during oogenesis. Here we show that deleterious mtDNA mutations are abundant in ovulated mature mouse oocytes and preimplantation embryos recovered from PolG mutator females but not in their live offspring. This implies that purifying selection acts not in the maternal germline per se, but during post-implantation development. We further show that oocyte mtDNA mutations can be captured and stably maintained in embryonic stem cells and then reintroduced into chimeras, thereby allowing examination of the effects of specific mutations on fetal and postnatal development.

Indexed as

MutationAnimalsBlastocystDNA, MitochondrialEmbryonic DevelopmentFemaleMiceMitochondriaOocytesOogenesisDNA, MitochondrialmitochondriamtDNAoocyte

Identifiers

PMID31621839
PMCPMC7068114
OpenAlexW2980850988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.